- Raised funding round
About
Diabest Botanical Drugs has developed a dietary supplement to support blood glucose levels, based on Sarcopoterium spinosum extract to treat metabolic diseases. The company's treatment integrates a proprietary botanical extract method and optimized growing protocol for S. spinosum to maintain healthy blood sugar levels and avoid diabetic complications. Diabest's R&D has found that S. spinosum root extract exerts a significant anti-diabetic effect in mice. Other R&D activities include plant harvesting and production of dry extract and capsulation, optimization of growing protocol, and the characterization of S. spinosum ecotypes to generate increased biological activity. While focused on type-2 diabetes, the technology could potentially treat a wide range of metabolic disorders.
Funding history · 1 round · — total
Q&A
- What is Diabest Botanical Drugs' primary focus?
- Diabest Botanical Drugs focuses on developing a botanical dietary supplement to support blood glucose levels, primarily for treating metabolic diseases like type-2 diabetes.
- What is the key ingredient in Diabest Botanical Drugs' supplement?
- The company's supplement is based on Sarcopoterium spinosum extract.
- What is the current status of Diabest Botanical Drugs?
- Diabest Botanical Drugs is currently inactive, having ceased operations in September 2023.
- When was Diabest Botanical Drugs founded?
- Diabest Botanical Drugs was founded in August 2011.
- Who are the co-founders of Diabest Botanical Drugs?
- The co-founders of Diabest Botanical Drugs are Yitshak Francis and Tovit Rosenzweig.
- What is the product stage of Diabest Botanical Drugs' offering?
- The product is in the clinical trial stage.
- Has Diabest Botanical Drugs secured any patents?
- Yes, Diabest Botanical Drugs holds one patent.
- Which investor participated in a funding round for Diabest Botanical Drugs?
- Martal Capital participated in a funding round for Diabest Botanical Drugs.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/5497650 |
Identifiers & details
| Founded | 2011-8 |
|---|---|
| Status reason | Non Active, Sep 2023 ceased to operate |